AI assistant
QUEST DIAGNOSTICS INC — Director's Dealing 2026
Feb 20, 2026
30275_dirs_2026-02-20_09980c97-92e7-4060-ab16-1571f0037e34.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
Period of Report: 2026-02-18
Reporting Person: SAMAD SAM (Executive Vice President & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-18 | Common Stock | A | 3965 | — | Acquired | 29706 | Direct |
| 2026-02-18 | Common Stock | F | 855 | $210.01 | Disposed | 28851 | Direct |
| 2026-02-18 | Common Stock | F | 1010 | $206.99 | Disposed | 27841 | Direct |
| 2026-01-28 | Common Stock | A | 69 | $183.514 | Acquired | 27910 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Non-Qualifed Stock Option (right to buy) | $204.96 | A | 18303 | Acquired | 2036-02-18 | Common Stock (18303) | Direct |
Footnotes
F1: Represents an award of restricted stock units.
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
F3: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
F4: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.